144 related articles for article (PubMed ID: 18234298)
1. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
[TBL] [Abstract][Full Text] [Related]
2. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nasu K; Narahara H
Gynecol Oncol; 2008 Nov; 111(2):336-43. PubMed ID: 18790523
[TBL] [Abstract][Full Text] [Related]
3. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2008 May; 21(5):637-43. PubMed ID: 18425357
[TBL] [Abstract][Full Text] [Related]
4. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
5. M344 is a novel synthesized histone deacetylase inhibitor that induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Gynecol Oncol; 2006 Apr; 101(1):108-13. PubMed ID: 16263156
[TBL] [Abstract][Full Text] [Related]
6. Anti-neoplastic effect of β-hydroxyisovalerylshikonin on a human choriocarcinoma cell line.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Mol Med Rep; 2010; 3(3):515-8. PubMed ID: 21472272
[TBL] [Abstract][Full Text] [Related]
7. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
Ueda T; Takai N; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
[TBL] [Abstract][Full Text] [Related]
8. CBHA is a family of hybrid polar compounds that inhibit histone deacetylase, and induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Matsuda K; Kusumoto M; Narahara H
Oncology; 2006; 70(2):97-105. PubMed ID: 16601366
[TBL] [Abstract][Full Text] [Related]
9. Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells.
Li H; Takai N; Yuge A; Furukawa Y; Tsuno A; Tsukamoto Y; Kong S; Moriyama M; Narahara H
Cancer Lett; 2010 Nov; 297(2):198-206. PubMed ID: 20547442
[TBL] [Abstract][Full Text] [Related]
10. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Oncol Rep; 2008 Mar; 19(3):749-53. PubMed ID: 18288411
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Anticancer Res; 2006; 26(2A):939-45. PubMed ID: 16619490
[TBL] [Abstract][Full Text] [Related]
12. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2010 Jan; 25(1):97-103. PubMed ID: 19956907
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anti-neoplastic effect of AG1478 in combination with cisplatin or paclitaxel on human endometrial and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Mol Med Rep; 2010; 3(3):479-84. PubMed ID: 21472266
[TBL] [Abstract][Full Text] [Related]
14. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
Masuda Y; Nishida A; Hori K; Hirabayashi T; Kajimoto S; Nakajo S; Kondo T; Asaka M; Nakaya K
Oncogene; 2003 Feb; 22(7):1012-23. PubMed ID: 12592388
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
Ishii T; Kira N; Yoshida T; Narahara H
Tumour Biol; 2013 Feb; 34(1):285-91. PubMed ID: 23150173
[TBL] [Abstract][Full Text] [Related]
16. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
Takai N; Narahara H
Curr Med Chem; 2007; 14(24):2548-53. PubMed ID: 17979707
[TBL] [Abstract][Full Text] [Related]
17. C2-ceramide exhibits antiproliferative activity and potently induces apoptosis in endometrial carcinoma.
Takai N; Ueda T; Kawano Y; Nishida M; Nasu K; Narahara H
Oncol Rep; 2005 Nov; 14(5):1287-91. PubMed ID: 16211298
[TBL] [Abstract][Full Text] [Related]
18. Silymarin induces cell cycle arrest and apoptosis in ovarian cancer cells.
Fan L; Ma Y; Liu Y; Zheng D; Huang G
Eur J Pharmacol; 2014 Nov; 743():79-88. PubMed ID: 25242120
[TBL] [Abstract][Full Text] [Related]
19. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
Ahn MY; Jung JH; Na YJ; Kim HS
Gynecol Oncol; 2008 Jan; 108(1):27-33. PubMed ID: 17920664
[TBL] [Abstract][Full Text] [Related]
20. Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo.
Fister S; Günthert AR; Emons G; Gründker C
Cancer Res; 2007 Feb; 67(4):1750-6. PubMed ID: 17308117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
